Gamma-aminobutyric acid type A receptor alpha-3 beta-gamma-2 benzodiazepine site (GABA_A receptor α3βγ2 BZD site)

The GABA_A receptor α3βγ2 benzodiazepine site is a distinct allosteric regulatory site located at the interface of the α3 and γ2 subunits within the pentameric GABA_A receptor complex. This receptor functions as a ligand-gated chloride channel, serving as the primary mediator of fast inhibitory neurotransmission in the mammalian central nervous system (Sigel & Steinmann, 2012, J. Biol. Chem. [1]). The α3 subunit is highly expressed in the thalamic reticular nucleus, spinal cord dorsal horn, and various cortical regions, where it plays a crucial role in modulating sensory processing and motor control (Pirker et al., 2000, Neuroscience [2]). Pharmacological targeting of this site, particularly through positive allosteric modulators, enhances GABA-mediated inhibition, which is associated with anxiolytic, muscle-relaxant, and analgesic properties (Rudolph & Knoflach, 2011, Nat. Rev. Drug Discov. [3]). Unlike the α1-containing receptors that primarily mediate sedation, the α3-containing receptors are considered key targets for developing non-sedating anxiolytics and treatments for neuropathic pain (Munro et al., 2009, Neuropharmacology [4]). Consequently, this site is a major focus in neuropharmacology for addressing conditions like generalized anxiety disorder and chronic pain syndromes while minimizing common benzodiazepine side effects (Atack, 2011, Curr. Top. Med. Chem. [5]).

Other names

α3-containing GABA_A receptorGABRA3-containing receptorBenzodiazepine receptor subtype α3GABA(A) receptor subunit alpha-3GABA_A receptor alpha-3 beta-gamma-2 complex

Positive allosteric modulation of GABA-induced chloride currents